Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2002European Journal of Neurology

No difference in efficacy of two different doses of intravenous immunoglobulins in MS: clinical and MRI assessment

View Full Paper
Ask AI
Bookmark
Share

Authors

MLMagdalena LewańskaMSMalgorzata Siger–ZajdelKSKrzysztof SelmajUniversity of Łódź

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lewańska et al. (2002) studied this question.

synapsesocial.com/papers/6a950acfc449400cd7827d57https://doi.org/10.1046/j.1468-1331.2002.00500.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Complications of intravenous immune globulin treatment in neurologic disease1996 · 213 citations
  2. 2Glatiramer acetate (Copaxone) treatment in relapsing–remitting MS2000 · 141 citations
  3. 3Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.1996 · 106 citations
  4. 4MRI in the diagnosis of MS1988 · 639 citations